Skip to main content
Clinical Trials/TCTR20201108003
TCTR20201108003CompletedPhase 3

The Effect of Antenatal Dexamethasone to Improve Respiratory Neonatal Outcomes in Late Preterm Birth :A Randomized Controlled Trial

none0 sites194 target enrollmentStarted: November 8, 2020Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
194

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 35 Years (—)
Sex
Male

Inclusion Criteria

  • Criteria for inclusion in the study were women (a) had preterm labor defined as regular uterine contractions before 37 weeks accompanied by a change of cervical dilatation, effacement, or both, or initial presentation with regular contractions and cervical dilatation at least 2 cm (16) or (b) had spontaneous rupture of membranes (preterm PROM), diagnosed by pooling of fluid at posterior fornix with speculum examination, positive cough test and positive alkaline pH test or (c) had fetal or maternal indications for delivery between 34 and 36+6 weeks gestation, such as placenta previa or fetal growth restriction.

Exclusion Criteria

  • We excluded women with multiple gestations, those who had received a previous course of corticosteroids, infection or chorioamnionitis (fetal tachycardia>160 bpm, maternal fever > 37.8 °C and foul smelling amniotic fluid) during labor, overt diabetes mellitus, gestational diabetes mellitus, cervical dilation more than 5 centimeters, thrombocytopenia, allergy to corticosteroids, preeclampsia severe feature and HELP syndrome.

Investigators

Sponsor
none

Similar Trials